Singh N - Search Results

1

Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline.

Daly ME, Singh N, Ismaila N, Antonoff MB, Arenberg DA, Bradley J, David E, Detterbeck F, Früh M, Gubens MA, Moore AC, Padda SK, Patel JD, Phillips T, Qin A, Robinson C, Simone CB 2nd. Daly ME, et al. Among authors: singh n. J Clin Oncol. 2022 Apr 20;40(12):1356-1384. doi: 10.1200/JCO.21.02528. Epub 2021 Dec 22. J Clin Oncol. 2022. PMID: 34936470 Review.

2

Intercycle delays during chemotherapy of non-small cell lung cancer in a health care resource-constrained setting and their effect on overall survival.

Singh N, Aggarwal AN, Behera D, Jindal SK. Singh N, et al. J Thorac Oncol. 2010 Feb;5(2):236-9. doi: 10.1097/JTO.0b013e3181c3f5f7. J Thorac Oncol. 2010. PMID: 20101147 Free article.

3

Clinical outcomes in non-small-cell lung cancer in relation to expression of predictive and prognostic biomarkers.

Singh N, Bal A, Aggarwal AN, Das A, Behera D. Singh N, et al. Future Oncol. 2010 May;6(5):741-67. doi: 10.2217/fon.10.30. Future Oncol. 2010. PMID: 20465389 Review.

4

Management of advanced lung cancer in resource-constrained settings: a perspective from India.

Singh N, Aggarwal AN, Behera D. Singh N, et al. Expert Rev Anticancer Ther. 2012 Nov;12(11):1479-95. doi: 10.1586/era.12.119. Expert Rev Anticancer Ther. 2012. PMID: 23249112 Review.

5

Pleural tuberculosis following lung cancer chemotherapy: a report of two cases proven pathologically by pleural biopsy.

Madan K, Singh N, Das A, Behera D. Madan K, et al. Among authors: singh n. BMJ Case Rep. 2013 Jan 22;2013:bcr2012008196. doi: 10.1136/bcr-2012-008196. BMJ Case Rep. 2013. PMID: 23345502 Free PMC article.

6

Combination of intravitreal bevacizumab and systemic therapy for choroidal metastases from lung cancer: report of two cases and a systematic review of literature.

Maturu VN, Singh N, Bansal P, Rai Mittal B, Gupta N, Behera D, Gupta A. Maturu VN, et al. Among authors: singh n. Med Oncol. 2014 Apr;31(4):901. doi: 10.1007/s12032-014-0901-z. Epub 2014 Mar 7. Med Oncol. 2014. PMID: 24604338 Review.

7

Association of Graded Folic Acid Supplementation and Total Plasma Homocysteine Levels With Hematological Toxicity During First-line Treatment of Nonsquamous NSCLC Patients With Pemetrexed-based Chemotherapy.

Singh N, Aggarwal AN, Kaur J, Behera D. Singh N, et al. Am J Clin Oncol. 2017 Feb;40(1):75-82. doi: 10.1097/COC.0000000000000111. Am J Clin Oncol. 2017. PMID: 25089530

8

Lung cancer with cavitation: a distinct subgroup of non-small cell lung cancer associated with poor overall survival.

Singh N, Behera D. Singh N, et al. Respir Investig. 2015 May;53(3):133-4. doi: 10.1016/j.resinv.2014.12.006. Epub 2015 Feb 19. Respir Investig. 2015. PMID: 25951101 No abstract available.

9

Total Plasma Homocysteine Level Assessment and Timing of Folate/B12 Supplementation Prior to Initiation of Pemetrexed-Based Chemotherapy for Nonsquamous Non-Small Cell Lung Cancer Patients: An Irrelevant Investigation, an Unnecessary Delay, or Both?

Singh N, Maturu VN, Behera D. Singh N, et al. Oncologist. 2015 Jul;20(7):e21. doi: 10.1634/theoncologist.2015-0040. Epub 2015 Jun 11. Oncologist. 2015. PMID: 26069280 Free PMC article.

10

Inclusion of Lymphangitis as a Descriptor in the New TNM Staging of Lung Cancer: Filling Up the Blank Spaces.

Singh N, Baldi M, Behera D. Singh N, et al. J Thorac Oncol. 2015 Dec;10(12):e119. doi: 10.1097/JTO.0000000000000682. J Thorac Oncol. 2015. PMID: 26709485 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,059 results

Search Page